BackTable Vascular & Interventional Ep. 565 Resorbable Embolics in MSK Embolizations with Dr. Keerthi Prasad
11 snips
Aug 19, 2025 Dr. Keerthi Prasad, an interventional radiologist from Indiana, discusses the innovative use of resorbable embolics in musculoskeletal interventions. He shares technical insights and specific embolic agents like Imipenem and Lipiodol. Clinical experiences illustrate their efficacy in treating conditions such as knee arthritis and plantar fasciitis. Dr. Prasad emphasizes the importance of partnering with outpatient labs and encourages wider accessibility to these evolving treatments that could reshape patient care.
AI Snips
Chapters
Transcript
Episode notes
Scale MSK Care With Outpatient Labs
- Build outpatient MSK embolization programs (OBLs/MSO model) to expand access and keep IR ownership in care delivery.
- Train local IRs in efficient outpatient technique to scale services where patients already seek care.
Start With Available Resorbable Embolics
- Try resorbable embolics (imipenem, lipiodol, Ecobee, Nexsphere-F) for MSK embolization when appropriate.
- Order imipenem from regular distributors and experiment with reconstitution ratios to find your preferred mix.
Nexsphere-F Bridges Size And Resorption
- Nexsphere-F targets 100–300 µm with rapid resorption, matching microsphere behavior while avoiding tiny-particle downsides.
- Rapid resorption (1–2 days) allows predictable temporary occlusion with faster recanalization.